DC Funds, LP 13F holdings
DC Funds, LP reported 3 positions with a total reported value of $1.3M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: TCRX TSCAN THERAPEUTICS INC (49.3%), BRNS BARINTHUS BIOTHERAPEUTICS PL (33.8%), HOWL WEREWOLF THERAPEUTICS INC (16.9%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when DC Funds, LP files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
3 largest of 3 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| TCRX TSCAN THERAPEUTICS INC | 630,000 | $617.5K | 49.3% |
| BRNS BARINTHUS BIOTHERAPEUTICS PL | 642,204 | $423.9K | 33.8% |
| HOWL WEREWOLF THERAPEUTICS INC | 589,102 | $212.0K | 16.9% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30
No new positions.
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
No position was decreased.
CIK 1869028 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
